126 related articles for article (PubMed ID: 20100574)
1. Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation.
Soria-Gómez E; Guzmán K; Pech-Rueda O; Montes-Rodríguez CJ; Cisneros M; Prospéro-García O
Pharmacol Res; 2010 May; 61(5):379-84. PubMed ID: 20100574
[TBL] [Abstract][Full Text] [Related]
2. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.
Murillo-Rodríguez E; Vázquez E; Millán-Aldaco D; Palomero-Rivero M; Drucker-Colin R
Eur J Pharmacol; 2007 May; 562(1-2):82-91. PubMed ID: 17336288
[TBL] [Abstract][Full Text] [Related]
3. Role of the area postrema in the hypophagic effects of oleoylethanolamide.
Romano A; Gallelli CA; Koczwara JB; Braegger FE; Vitalone A; Falchi M; Micioni Di Bonaventura MV; Cifani C; Cassano T; Lutz TA; Gaetani S
Pharmacol Res; 2017 Aug; 122():20-34. PubMed ID: 28535974
[TBL] [Abstract][Full Text] [Related]
4. High dietary fat intake influences the activation of specific hindbrain and hypothalamic nuclei by the satiety factor oleoylethanolamide.
Romano A; Karimian Azari E; Tempesta B; Mansouri A; Micioni Di Bonaventura MV; Ramachandran D; Lutz TA; Bedse G; Langhans W; Gaetani S
Physiol Behav; 2014 Sep; 136():55-62. PubMed ID: 24802360
[TBL] [Abstract][Full Text] [Related]
5. Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats.
Murillo-Rodríguez E; Palomero-Rivero M; Millán-Aldaco D; Arias-Carrión O; Drucker-Colín R
PLoS One; 2011; 6(7):e20766. PubMed ID: 21779318
[TBL] [Abstract][Full Text] [Related]
6. Oleoylethanolamide: effects on hypothalamic transmitters and gut peptides regulating food intake.
Serrano A; Pavón FJ; Tovar S; Casanueva F; Señarís R; Diéguez C; de Fonseca FR
Neuropharmacology; 2011 Mar; 60(4):593-601. PubMed ID: 21172362
[TBL] [Abstract][Full Text] [Related]
7. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
[TBL] [Abstract][Full Text] [Related]
8. Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake.
Provensi G; Coccurello R; Umehara H; Munari L; Giacovazzo G; Galeotti N; Nosi D; Gaetani S; Romano A; Moles A; Blandina P; Passani MB
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11527-32. PubMed ID: 25049422
[TBL] [Abstract][Full Text] [Related]
9. 2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats.
Pérez-Morales M; De La Herrán-Arita AK; Méndez-Díaz M; Ruiz-Contreras AE; Drucker-Colín R; Prospéro-García O
Pharmacol Biochem Behav; 2013 Jul; 108():1-7. PubMed ID: 23603032
[TBL] [Abstract][Full Text] [Related]
10. Evidence that activation of nuclear peroxisome proliferator-activated receptor alpha (PPARα) modulates sleep homeostasis in rats.
Murillo-Rodríguez E; Guzmán K; Arankowsky-Sandoval G; Salas-Crisóstomo M; Jiménez-Moreno R; Arias-Carrión O
Brain Res Bull; 2016 Oct; 127():156-163. PubMed ID: 27646482
[TBL] [Abstract][Full Text] [Related]
11. Brain molecules and appetite: the case of oleoylethanolamide.
Sarro-Ramírez A; Sánchez-López D; Tejeda-Padrón A; Frías C; Zaldívar-Rae J; Murillo-Rodríguez E
Cent Nerv Syst Agents Med Chem; 2013 Mar; 13(1):88-91. PubMed ID: 23464987
[TBL] [Abstract][Full Text] [Related]
12. The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons.
Romano A; Cassano T; Tempesta B; Cianci S; Dipasquale P; Coccurello R; Cuomo V; Gaetani S
Peptides; 2013 Nov; 49():21-6. PubMed ID: 23959001
[TBL] [Abstract][Full Text] [Related]
13. The hypophagic factor oleoylethanolamide differentially increases c-fos expression in appetite regulating centres in the brain of wild type and histamine deficient mice.
Umehara H; Fabbri R; Provensi G; Passani MB
Pharmacol Res; 2016 Nov; 113(Pt A):100-107. PubMed ID: 27543461
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats.
Murillo-Rodríguez E; Millán-Aldaco D; Palomero-Rivero M; Mechoulam R; Drucker-Colín R
FEBS Lett; 2006 Aug; 580(18):4337-45. PubMed ID: 16844117
[TBL] [Abstract][Full Text] [Related]
15. Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats.
Herrera-Solís A; Vásquez KG; Prospéro-García O
Pharmacol Biochem Behav; 2010 Mar; 95(1):106-12. PubMed ID: 20056119
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin microinjection into forebrain sites induces wakefulness and feeding in rats.
Szentirmai E; Kapás L; Krueger JM
Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R575-85. PubMed ID: 16917015
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties.
Astarita G; Di Giacomo B; Gaetani S; Oveisi F; Compton TR; Rivara S; Tarzia G; Mor M; Piomelli D
J Pharmacol Exp Ther; 2006 Aug; 318(2):563-70. PubMed ID: 16702440
[TBL] [Abstract][Full Text] [Related]
18. The anorexigenic peptide cocaine-and-amphetamine-regulated transcript modulates rem-sleep in rats.
Méndez-Díaz M; Domínguez Martín E; Pérez Morales M; Ruiz-Contreras AE; Navarro L; Prospéro-García O
Neuropeptides; 2009 Dec; 43(6):499-505. PubMed ID: 19720396
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoids and sleep.
Prospéro-García O; Amancio-Belmont O; Becerril Meléndez AL; Ruiz-Contreras AE; Méndez-Díaz M
Neurosci Biobehav Rev; 2016 Dec; 71():671-679. PubMed ID: 27756691
[TBL] [Abstract][Full Text] [Related]
20. Effects on sleep of melanin-concentrating hormone (MCH) microinjections into the dorsal raphe nucleus.
Lagos P; Torterolo P; Jantos H; Chase MH; Monti JM
Brain Res; 2009 Apr; 1265():103-10. PubMed ID: 19230831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
